SLNO
SLNO
NASDAQ · Biotechnology

Soleno Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$52.95
+0.00 (+0.00%)
As of May 10, 10:02 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -62.3% upside
Low Target $16.99
Average Target $19.95
High Target $27.29
Current Price $52.95
Current
$52.95
Target
$19.95
$16.99 $19.95 avg $27.29
Scenario Analysis
Bear Case
$16.99
-67.9%
Low target
Base Case
$19.95
-62.3%
Avg target
Bull Case
$27.29
+-48.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$90.32
-41.4% from high
52-Week Low
$29.43
+79.9% from low
50-Day SMA
$44.35
+19.4% vs SMA
200-Day SMA
$63.31
-16.4% vs SMA
RSI (14)
47.2
Neutral
Target vs 52W High
$19.95
-77.9% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $0.69
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%